Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Sarcoma, Ewing × Immune Checkpoint Inhibitors × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 5 Squamous Cell Carcinoma of Head and Neck 2 Solid Cancers 2 Neoplasms 2 Melanoma 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Sarcopenia 1 SCLC 1 Rectal Neoplasms 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Mouth Neoplasms 1 Immune-Related Adverse Events 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1 Biliary Tract Neoplasms 1

Interventions

Temozolomide 7 Vincristine 5 Irinotecan 5 Cyclophosphamide 4 Etoposide 3 etoposide phosphate 2 cabozantinib 2 abemaciclib 2 Ifosfamide 2 Doxorubicin 2 silmitasertib 1 romiplostim 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 liposomal doxorubicin 1 ganitumab 1 fludarabine 1 dinutuximab 1 Zoledronic Acid 1 X-Rays 1 Whole-Body Irradiation 1 Weight-Bearing 1 Topotecan 1 Tacrolimus 1 Specimen Handling 1 Sirolimus 1 Range of Motion, Articular 1 Radiotherapy, Image-Guided 1 Radiosurgery 1 Radiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡